Delisted
No longer trades. Fund positions are valued at the last price we have, $115.07 on May 15, 2026. View SEC filing

ARCELLX INC
ACLXHealthcare
ACLX (ARCELLX INC) is held by 0 institutional investors as of Q2 2026.
No verdict yet — fewer than 2 funds hold ACLX.
Top Holders
Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available
Checking access…
Showing 1-20 of 118
1 / 6
| Insider | Trade | Traded |
|---|---|---|
| Elghandour Rami | U 198K sh | |
| Behbahani Ali | U 3K sh | |
| Gilson Michelle | U 67K sh | |
| Elghandour Rami | U 101K sh | |
| Galligan Andrew H | U 5K sh | |
| Elghandour Rami | U 219K sh | |
| Heery Christopher | U 24K sh | |
| Behbahani Ali | U 2K sh | |
| Lubner David Charles | U 22K sh | |
| Gilson Michelle | U 5K sh |
Loading Congress trades…
| Filer | Stake | Filed |
|---|---|---|
| Paradigm BioCapital Advisors LP | 0.0% | |
| Vestal Point Capital, LP | 0.0% | |
| New Enterprise Associates 15, L.P. | 0.0% | |
| GILEAD SCIENCES, INC. | 100.0% | |
| Rami Elghandour | 0.0% | |
| The Vanguard Group | 0.0% | |
| T. Rowe Price Investment Management, Inc. | 4.5% | |
| FMR LLC | 0.5% | |
| Paradigm BioCapital Advisors LP | 9.9% | |
| RA Capital Management, L.P. | 2.2% |
Continue exploring
Other Healthcare stocks held by institutions
456 holders · $264.6B
455 holders · $846.2B
442 holders · $208.3B
438 holders · $117B
437 holders · $430.7B
432 holders · $256.6B
425 holders · $314.1B
425 holders · $109.3B
418 holders · $123.6B
412 holders · $151.2B
Questions investors ask about ACLX
Who owns ACLX?
0 institutional investors held ACLX on June 30, 2026, according to their 13F filings.
How many hedge funds hold ACLX?
0 institutional investors reported ACLX in their 13F filings for the quarter ended June 30, 2026.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer